[Presence of anti-SRP and anti-M2 antibodies in patients with severe polymyositis]. 2013

E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
Unidad de Gestión Clínica, Laboratorio y Alergia, Complejo Hospitalario de Jaén, Jaén, España. Electronic address: eocanap@gmail.com.

UI MeSH Term Description Entries
D003882 Dermatomyositis A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6) Polymyositis-Dermatomyositis,Dermatomyositis, Adult Type,Dermatomyositis, Childhood Type,Dermatopolymyositis,Juvenile Dermatomyositis,Juvenile Myositis,Adult Type Dermatomyositis,Childhood Type Dermatomyositis,Dermatomyositis, Juvenile,Myositis, Juvenile,Polymyositis Dermatomyositis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017285 Polymyositis Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9) Myositis, Multiple,Polymyositis Ossificans,Polymyositis, Idiopathic,Idiopathic Polymyositides,Idiopathic Polymyositis,Multiple Myositis,Myositides, Multiple,Ossificans, Polymyositis,Polymyositides,Polymyositides, Idiopathic

Related Publications

E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
January 2016, The Pan African medical journal,
E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
July 2010, Clinical rheumatology,
E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
January 2012, Rinsho shinkeigaku = Clinical neurology,
E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
August 2007, Clinical rheumatology,
E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
January 1993, The American journal of medicine,
E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
March 1973, Lancet (London, England),
E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
January 2012, Internal medicine (Tokyo, Japan),
E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
May 1999, The Journal of investigative dermatology,
E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
February 1993, Harefuah,
E Ocaña Pérez, and M Romero Jurado, and A M Peña Casas, and A Martínez Cañamero
October 1995, Clinical and experimental immunology,
Copied contents to your clipboard!